22-27982850-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145418.2(TTC28):c.6817G>A(p.Gly2273Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000395 in 1,543,538 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145418.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000537 AC: 8AN: 148926Hom.: 0 AF XY: 0.0000381 AC XY: 3AN XY: 78768
GnomAD4 exome AF: 0.0000295 AC: 41AN: 1391320Hom.: 0 Cov.: 32 AF XY: 0.0000277 AC XY: 19AN XY: 685170
GnomAD4 genome AF: 0.000131 AC: 20AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2024 | The c.6817G>A (p.G2273S) alteration is located in exon 23 (coding exon 23) of the TTC28 gene. This alteration results from a G to A substitution at nucleotide position 6817, causing the glycine (G) at amino acid position 2273 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at